What top creators are saying about Centene Corporation(CNC)

Significant quarterly decline driven by unfavorable government pricing and rising costs.

The company is negatively impacted by changes in Medicaid, where the end of a COVID-era rule has left it with a sicker, more expensive patient pool, causing medical loss ratios to 'explode'.

Part of the worst-performing healthcare subsector (medical insurance) due to higher-than-expected cost increases; the stock was down 33%.

Stock is down significantly (in the 40% to 53% range) due to 'absolute carnage' in the managed care sector from rising healthcare costs.

The CEO has been buying stock (nearly $500,000) after the price fell over 50%, signaling a belief that the sell-off was excessive and the company is fundamentally sound.

The CEO purchased nearly $500,000 of stock after it had fallen 60%, a 'buy the dip' scenario that suggests a belief the stock has bottomed out and may rebound.

A Congressman on the subcommittee investigating Medicaid billing practices purchased the stock, which is seen as a potentially bullish signal that the investigation's impact may be less severe than feared by the market.

Three members of Congress sold their shares in the weeks before a major bill passed, after which the stock's value dropped by 50%. The coordinated selling was presented as a major red flag and a powerful warning sign.

Identified as a clear loser from the new bill, which includes major cuts to Medicaid, directly threatening the company's revenue and growth prospects.

Could be negatively impacted by a reduction in Medicaid enrollees if eligibility rules are tightened, representing a direct headwind to revenue.

The company lowered its guidance, causing its stock to drop 40% and triggering a sector-wide sell-off in health insurance stocks.